ArticleBone marrow transplantation2007

Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.

M Tomblyn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.